Wilson Sonsini Goodrich & Rosati advised Netflix on the transaction, and Davis Polk & Wardwell advised the underwriters. Netflix, Inc. (Nasdaq: NFLX) completed its inaugural investment...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised iRhythm Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the initial purchasers. iRhythm Technologies, Inc. (Nasdaq: IRTC) announced its...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised the representative of the initial purchasers on the offering. Vishay Intertechnology, Inc. (NYSE: VSH) announced it has completed its offering of $750 million aggregate...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering. Coherus BioSciences, Inc. (“Coherus”, Nasdaq:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Mirion Technologies on the offering. Mirion Technologies, Inc. announced a registered direct offering of 17,142,857 shares of its Class A common stock at...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised RxSight, and Davis Polk advised the sole bookrunning manager in the offering. RxSight, Inc. announced a $50 million SEC-registered follow-on offering of 4,000,000...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Davis Polk represented Jefferies LLC, the sole book-running manager, in the offering. EDAP TMS S.A. executed $23 million public offering of 3,066,667 American Depositary Shares (which includes...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sole book-running manager and representative of the several underwriters for the offerings. SVB Financial Group executed the offerings of $650 million aggregate...
You must be a Standard 1 Year member to access this content.
